Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 2Phase 1/2 1

Status

Recruiting 10Not yet recruiting 4Active not recruiting 3Terminated 1

Sponsor Class

INDUSTRY 7OTHER 3

Study Type

Interventional 9Observational 1

Sponsor

Cancer Type

Breast 10Tumor-Agnostic 2Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 9Neoplasm, Residual 1HER2-positive Breast Cancer 1

Interventions

pembrolizumab 78Fulvestrant 76Carboplatin 74Trastuzumab 71Capecitabine 70Letrozole 63Cyclophosphamide 61Paclitaxel 60Specimen Handling 54pertuzumab 52Docetaxel 50abemaciclib 46ribociclib 45Anastrozole 36Magnetic Resonance Spectroscopy 35130-nm albumin-bound paclitaxel 35trastuzumab deruxtecan 34Blood Specimen Collection 33exemestane 32Tamoxifen 32Biopsy 32sacituzumab govitecan 31Gemcitabine 30Epirubicin 29pyrotinib 28palbociclib 28Drug Therapy 28Surveys and Questionnaires 27Injections 27eribulin 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

10 trials
RecentStart dateEnrollment
Recruiting × inavolisib × Breast × Clear all
NCT06790693 2026-06-03

INAVO123

Hoffmann-La Roche

Phase 3 Recruiting
450 enrolled
Breast

Breast Neoplasms

NCT05894239 2026-05-29

INAVO122

Hoffmann-La Roche

Phase 3 Recruiting
230 enrolled
Breast

Breast Neoplasms

NCT07054190 2026-05-26

A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer

Hoffmann-La Roche

Phase 2 Recruiting
60 enrolled
Breast

Breast Neoplasms

NCT07347600 2026-05-18

reaINAVO

Hoffmann-La Roche

Recruiting
500 enrolled
Breast

Breast Neoplasms

NCT07405801 2026-05-18

A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

Hoffmann-La Roche

Phase 2 Recruiting
80 enrolled
Breast

Breast Neoplasms

NCT07368998 2026-05-11

optINAVO

Hoffmann-La Roche

Phase 2 Recruiting
80 enrolled
Breast

Breast Neoplasms

NCT03424005 2026-03-16

Morpheus-panBC

Hoffmann-La Roche

Phase 1/2 Recruiting
792 enrolled
Breast

Breast Neoplasms

NCT05708235 2026-03-05

MiRaDoR

MedSIR

Phase 2 Recruiting
976 enrolled
Breast

Breast Neoplasms, Neoplasm, Residual

NCT05332561 2025-03-20

Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)

German Cancer Research Center

Phase 2 Recruiting
240 enrolled
Breast

Breast Neoplasms

NCT05306041 2025-02-17

GeparPiPPa

GBG Forschungs GmbH

Phase 2 Recruiting
170 enrolled
Breast

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡